000 02275 a2200577 4500
005 20250515055916.0
264 0 _c20070802
008 200708s 0 0 eng d
022 _a0363-6135
024 7 _a10.1152/ajpheart.01330.2006
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRocic, Petra
245 0 0 _aOptimal reactive oxygen species concentration and p38 MAP kinase are required for coronary collateral growth.
_h[electronic resource]
260 _bAmerican journal of physiology. Heart and circulatory physiology
_cJun 2007
300 _aH2729-36 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aAcetophenones
_xpharmacology
650 0 4 _aAnimals
650 0 4 _aBlood Flow Velocity
650 0 4 _aCells, Cultured
650 0 4 _aCollateral Circulation
_xdrug effects
650 0 4 _aCoronary Circulation
_xdrug effects
650 0 4 _aCoronary Vessels
_xsurgery
650 0 4 _aDisease Models, Animal
650 0 4 _aDitiocarb
_xpharmacology
650 0 4 _aEndothelial Cells
_xdrug effects
650 0 4 _aEnzyme Inhibitors
_xpharmacology
650 0 4 _aHumans
650 0 4 _aImidazoles
_xpharmacology
650 0 4 _aLigation
650 0 4 _aMAP Kinase Signaling System
_xdrug effects
650 0 4 _aMale
650 0 4 _aMyocardial Reperfusion Injury
_xenzymology
650 0 4 _aNADPH Oxidases
_xantagonists & inhibitors
650 0 4 _aNeovascularization, Physiologic
650 0 4 _aOnium Compounds
_xpharmacology
650 0 4 _aOxygenases
_xantagonists & inhibitors
650 0 4 _aPyridines
_xpharmacology
650 0 4 _aRats
650 0 4 _aRats, Inbred WKY
650 0 4 _aReactive Oxygen Species
_xmetabolism
650 0 4 _aSuperoxide Dismutase
_xantagonists & inhibitors
650 0 4 _aVascular Endothelial Growth Factor A
_xmetabolism
650 0 4 _ap38 Mitogen-Activated Protein Kinases
_xantagonists & inhibitors
700 1 _aKolz, Christopher
700 1 _aReed, Ryan
700 1 _aPotter, Barry
700 1 _aChilian, William M
773 0 _tAmerican journal of physiology. Heart and circulatory physiology
_gvol. 292
_gno. 6
_gp. H2729-36
856 4 0 _uhttps://doi.org/10.1152/ajpheart.01330.2006
_zAvailable from publisher's website
999 _c16867052
_d16867052